Delic Corp Inc. DELCF Archives

TuesdayApr 04, 2023 11:50 am

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Inks LOI for Acquisition of Ketamine Wellness Centers

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has signed a letter of intent with Peter/PetraMD, the largest online provider of hormone therapy in the United States for the acquisition of Ketamine Wellness Centers. According to the announcement, the acquisition provides an incredible on-ramp into the ketamine space for Peter/PetraMD, which has more than 20 years of experience and nearly 100,000 patients across the United States. Ketamine Wellness Centers is the largest ketamine infusion therapy provider in the country. According to the announcement, Peter/PetraMD plans to maintain continuity of care…

ThursdayOct 27, 2022 11:46 am

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces Delic Labs’ Participation at 11th Annual MJBizCon

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced details regarding Delic Labs CSO and President Dr. Markus Roggen’s participation at the MJBizCon in Las Vegas, Nevada, on Nov. 15, 2022. With more than 1,400 exhibitors, 35,000 attendees and countless networking opportunities, MJBizCon is the world’s premier cannabis business conference and tradeshow. At this year’s event, Dr. Roggen will participate in MJBizScience Symposium’s panel discussion entitled, “R&D as a Business Tool: Maximizing Revenue by Focusing on the Scientific Method.” Alongside leading industry professionals, Dr. Roggen will highlight the…

ThursdaySep 29, 2022 10:59 am

QualityStocksNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) KWC Expands Insurance Coverage with Medicare for Ketamine Therapy Patients

Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has become one of a few U.S.-based ketamine therapy providers to offer Medicare coverage to patients at eight KWC clinics across the country. Under Medicare, KWC is accepting a limited number of patients for ketamine infusion therapy at Chicago, Denver, Houston, Jacksonville, Minneapolis, Tucson, Salt Lake City and Seattle clinics. In addition, KWC is providing the FDA-approved SPRAVATO(R) esketamine treatment at Houston, Jacksonville and Seattle locations for patients meeting the criteria for insurance coverage. “At Ketamine…

ThursdaySep 22, 2022 12:05 pm

QualityStocksNewsBreaks – Delic Holdings Corp.’s (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) KWC, VA-CCN Collaborate to Expand Access to SPRAVATO(R) Treatments

Ketamine Wellness Centers (“KWC”), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has expanded its partnership with the Veterans Administration Community Care Network (“VA-CCN”) to cover SPRAVATO(R) treatments at select clinics. VA-CCN patients experiencing treatment-resistant depression with prior authorization from the VA-CCN will now have access to treatments at the following KWC clinics: Mesa, Tucson, Phoenix, Denver, Seattle, Reno, Las Vegas, Houston and Dallas. “KWC works every day to provide the best, most effective treatments to those who need them most and our veterans, who suffer from various…

ThursdaySep 08, 2022 11:34 am

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO to Present at H.C. Wainwright Annual Global Investment Conference

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, announced that CEO Matt Stang will be participating in the 24th annual H.C. Wainwright Annual Global Investment Conference. The three-day event is scheduled for Sept. 12–14, 2022. During his presentation, Stang will provide a summary of the company’s focus on growing its clinic footprint and accepting a wider selection of insurance options; the presentation will also include Delic’s strategic outlook for the remainder of the year. In addition, Stang will be available for one-on-one meetings throughout the conference. Stang’s presentation will…

WednesdaySep 07, 2022 11:07 am

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO Makes Top-100 Innovation List, Company Postpones Meet Delic Event

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO Matt Stang was included in World Biz magazine’s Top-100 CEOs in Innovation for 2022. The announcement noted that Stang was recognized as a champion of creativity who is dedicated to making a positive environmental and social impact. Stand cofounded Delic Corp., which has grown into a leader in new medicines and treatments for a modern world. Stang led the company’s acquisition of the Ketamine Wellness Centers, and under his guidance, the company reported more than $1.5 million in total revenue in 2021 while more than quadrupling its net assets. This month, Stang…

TuesdayAug 16, 2022 1:12 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Names Key Management Positions

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, have announced advanced appointments for two key executives. According to the company, Delic Holdings cofounder and CEO Matt Stang has been named executive chair while COO Kevin Nicholson has been named CEO and will also join the company’s board of directors; Nicholson will continue to serve in his current role as CEO of Ketamine Wellness Centers (“KWC”). Before founding Delic, Stang owned and operated “High Times,”a leading source of cannabis news. As Delic CEO, Stang led the company in its acquisition of…

MondayAug 01, 2022 10:44 am

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Announces Completion of Debenture Offering

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has completed the sale of 1,240 units, with each unit consisting of one 4% senior secured $1,064 ‎principal amount convertible debenture and 16,369 share purchase warrants. The sale, which was resulted in gross proceeds of $1,240,000 for the company, was completed on July 27, 2022. According to the announcement, the principal amount and accrued but unpaid interest on each debenture is ‎convertible into common shares of the company; that conversion is done at the option of the holder at any ‎time following the…

ThursdayJul 21, 2022 11:24 am

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Reports on First Full-Year Revenue, Issues KWC Status Update

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has released an update on its both its financial and corporate status. According to the announcement, the company released its first end-of-year earnings report in May, which showed $1.5 million annual revenue and a growth in net assets from $2.1 million in 2020 to $10 million by 2021 year end, a 500% year-over-year increase. In addition, the company’s Ketamine Wellness Centers (“KWC”) are reporting impressive growth, offering an estimated 100,000 treatments so far at its 13 operational, state-of-the-art clinics; the company…

WednesdayJul 20, 2022 12:38 pm

QualityStocksNewsBreaks – Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Celebrates Third Recognition of Delic Labs’ Dr. Markus Roggen to Cannabis Scientist Power List

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, today announced that Dr. Markus Roggen, president and chief science officer for Delic Labs, was named to the Cannabis Scientist Power List for the third consecutive year. Due to his commitment to creating a body of work on cannabis research that will have a positive, lasting effect on the industry, Dr. Roggen is consistently recognized as one of the most influential figures in the processing professionals category. Under Dr. Roggen’s leadership, Delic Labs will transfer its cannabis sector expertise and experience…

Site Search

Company Search

Tag: Delic Corp Inc. DELCF